Most of the companies followin_老虎社区_美港股上老虎

Anulpr
2021-06-23

Most of the companies following SPAC for listing

Interesting 🤨

SoftBank-backed Pear Therapeutics agrees $1.6 billion SPAC deal

TOKYO, June 22 (Reuters) - SoftBank-backed healthcare startup Pear Therapeutics has agreed to go pub

SoftBank-backed Pear Therapeutics agrees $1.6 billion SPAC deal

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":129412919,"tweetId":"129412919","gmtCreate":1624380800031,"gmtModify":1634006934836,"author":{"id":3582370010626498,"idStr":"3582370010626498","authorId":3582370010626498,"authorIdStr":"3582370010626498","name":"Anulpr","avatar":"https://static.tigerbbs.com/66a9fd4dc3e08a3b8e42875455005117","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Most of the companies following SPAC for listing&nbsp;</p><p>Interesting 🤨&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>Most of the companies following SPAC for listing&nbsp;</p><p>Interesting 🤨&nbsp;</p></body></html>","text":"Most of the companies following SPAC for listing Interesting 🤨","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/129412919","repostId":1105214513,"repostType":4,"repost":{"id":"1105214513","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624360064,"share":"https://www.laohu8.com/m/news/1105214513?lang=&edition=full","pubTime":"2021-06-22 19:07","market":"us","language":"en","title":"SoftBank-backed Pear Therapeutics agrees $1.6 billion SPAC deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1105214513","media":"Reuters","summary":"TOKYO, June 22 (Reuters) - SoftBank-backed healthcare startup Pear Therapeutics has agreed to go pub","content":"<p>TOKYO, June 22 (Reuters) - SoftBank-backed healthcare startup Pear Therapeutics has agreed to go public through a merger with Thimble Point Acquisition Corp, a blank cheque company affiliated with an heir of the Pritzker family, creating a business valued at $1.6 billion.</p>\n<p>The deal announced on Tuesday will give the combined company $276 million in cash from Thimble Point’s trust account and a private investment in public equity (PIPE) of $125 million from investors including SoftBank, Temasek and 5AM Ventures.</p>\n<p>Pear considered further private fund raising, a traditional listing and a special purpose acquisition company (SPAC) merger before choosing the last following conversations with Thimble Point, its Chief Executive Corey McCann told Reuters.</p>\n<p>Boston- and San Francisco-based Pear, which offers app-based therapy and tracking tools for patients in treatment for insomnia and substance abuse, plans to use the funding influx to expand commercial opportunities and develop new programmes.</p>\n<p>SoftBank Group Corp’s $30 billion Vision Fund 2 led an $80 million Series D funding round in the startup in December. Pear is the latest SoftBank portfolio company to agree to a SPAC merger, with other examples including ride-hailer Grab.</p>\n<p>Thimble Point screened over 100 companies and did due diligence on 30 before striking a deal with Pear, said the SPAC’s CEO Elon Boms, who is also managing director of the Pritzker Vlock Family Office, which manages the wealth of Karen Pritzker.</p>\n<p>A second SPAC will launch in the “next week or two”, Boms said. The vehicles have raised record sums and offer targets an escape from the onerous reporting requirements of traditional listings, but have caught the attention of regulators.</p>\n<p>“My opinion is that there are five to ten high quality managers that will evolve out of this, and we hope to be one of them,” said Boms.</p>\n<p>The combined firm will list on the Nasdaq under the ticket symbol PEAR after the deal’s expected close in the second half of the year. (Reporting by Sam Nussey; Editing by Jan Harvey)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SoftBank-backed Pear Therapeutics agrees $1.6 billion SPAC deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSoftBank-backed Pear Therapeutics agrees $1.6 billion SPAC deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-22 19:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TOKYO, June 22 (Reuters) - SoftBank-backed healthcare startup Pear Therapeutics has agreed to go public through a merger with Thimble Point Acquisition Corp, a blank cheque company affiliated with an heir of the Pritzker family, creating a business valued at $1.6 billion.</p>\n<p>The deal announced on Tuesday will give the combined company $276 million in cash from Thimble Point’s trust account and a private investment in public equity (PIPE) of $125 million from investors including SoftBank, Temasek and 5AM Ventures.</p>\n<p>Pear considered further private fund raising, a traditional listing and a special purpose acquisition company (SPAC) merger before choosing the last following conversations with Thimble Point, its Chief Executive Corey McCann told Reuters.</p>\n<p>Boston- and San Francisco-based Pear, which offers app-based therapy and tracking tools for patients in treatment for insomnia and substance abuse, plans to use the funding influx to expand commercial opportunities and develop new programmes.</p>\n<p>SoftBank Group Corp’s $30 billion Vision Fund 2 led an $80 million Series D funding round in the startup in December. Pear is the latest SoftBank portfolio company to agree to a SPAC merger, with other examples including ride-hailer Grab.</p>\n<p>Thimble Point screened over 100 companies and did due diligence on 30 before striking a deal with Pear, said the SPAC’s CEO Elon Boms, who is also managing director of the Pritzker Vlock Family Office, which manages the wealth of Karen Pritzker.</p>\n<p>A second SPAC will launch in the “next week or two”, Boms said. The vehicles have raised record sums and offer targets an escape from the onerous reporting requirements of traditional listings, but have caught the attention of regulators.</p>\n<p>“My opinion is that there are five to ten high quality managers that will evolve out of this, and we hope to be one of them,” said Boms.</p>\n<p>The combined firm will list on the Nasdaq under the ticket symbol PEAR after the deal’s expected close in the second half of the year. (Reporting by Sam Nussey; Editing by Jan Harvey)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SFTBY":"软银集团"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105214513","content_text":"TOKYO, June 22 (Reuters) - SoftBank-backed healthcare startup Pear Therapeutics has agreed to go public through a merger with Thimble Point Acquisition Corp, a blank cheque company affiliated with an heir of the Pritzker family, creating a business valued at $1.6 billion.\nThe deal announced on Tuesday will give the combined company $276 million in cash from Thimble Point’s trust account and a private investment in public equity (PIPE) of $125 million from investors including SoftBank, Temasek and 5AM Ventures.\nPear considered further private fund raising, a traditional listing and a special purpose acquisition company (SPAC) merger before choosing the last following conversations with Thimble Point, its Chief Executive Corey McCann told Reuters.\nBoston- and San Francisco-based Pear, which offers app-based therapy and tracking tools for patients in treatment for insomnia and substance abuse, plans to use the funding influx to expand commercial opportunities and develop new programmes.\nSoftBank Group Corp’s $30 billion Vision Fund 2 led an $80 million Series D funding round in the startup in December. Pear is the latest SoftBank portfolio company to agree to a SPAC merger, with other examples including ride-hailer Grab.\nThimble Point screened over 100 companies and did due diligence on 30 before striking a deal with Pear, said the SPAC’s CEO Elon Boms, who is also managing director of the Pritzker Vlock Family Office, which manages the wealth of Karen Pritzker.\nA second SPAC will launch in the “next week or two”, Boms said. The vehicles have raised record sums and offer targets an escape from the onerous reporting requirements of traditional listings, but have caught the attention of regulators.\n“My opinion is that there are five to ten high quality managers that will evolve out of this, and we hope to be one of them,” said Boms.\nThe combined firm will list on the Nasdaq under the ticket symbol PEAR after the deal’s expected close in the second half of the year. (Reporting by Sam Nussey; Editing by Jan Harvey)","news_type":1},"isVote":1,"tweetType":1,"viewCount":78,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":54,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}